Wall Street stumbles as oil surges, and Lilly takes a new path on next-gen obesity drug

Wall Street declined as crude oil surged, CNBC reports. Eli Lilly is taking a new direction with its next-generation obesity medication—a key focus area for the pharmaceutical industry.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton